Nagendran Sukumar sold TSHA
November 28, 2025 · Form 4 insider transaction
Nagendran Sukumar sold 110,125 shares of Taysha Gene Therapies, Inc. at $4.75 per share, a transaction worth $523.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
110,125
Price
$4.75
Total value
$523.1K
InsiderNagendran Sukumar
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 28, 2025
Filing dateDecember 1, 2025
Shares owned after1,006,439
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.7248 to $4.8348 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2).